论文部分内容阅读
根据新指南,血管性血友病的治疗目的是使出血停止或者在手术时采取措施预防出血。许多常见的遗传性出血障碍至今仍没有相关的治疗指南。美国国家心肺和血液研究所(NHLBI)最近发布了第一个针对血管性血友病
According to the new guidelines, the goal of treatment for von Willebrand disease is to stop bleeding or take measures to prevent bleeding during surgery. Many common hereditary bleeding disorders so far there is no relevant treatment guidelines. The National Institute of Cardiopulmonary and Hematology (NHLBI) recently released the first vaccine for von Willebrand’s disease